Effect of connective tissue growth factor on the transdifferentation of human hypertrophic scar fibroblasts mediated by phosphatidylinositol 3-kinase/protein kinase B(P13KNKB)signal pathway

Jian-yi LIU,Shi-rong LI
DOI: https://doi.org/10.3969/j.issn.1008-6455.2008.03.030
2008-01-01
Abstract:Objective To explore if the effect of connective tissue growth factor on the transdifferentation of human hypertrophic scar fibroblasts is mediated by phosphatidylinositol 3-kinase/ protein kinase B(PI3K/PKB) signal pathway. Methods Human hypertrophic scar fibroblasts were cultured in vitro. The cells were divided into three groups: ①control group,②connective tissue growth factor(10 ng/ml)stimulated group,③PI3K inhibitor LY294002(10μmol/ L)pretreated and connective tissue growth factorstimulated group. The expression of a-smooth muscle actin was examined by western blot in human hypertrophic scar fibroblasts after 48 hours. The positive ratio of a-smooth muscle actin was examined by flow cytometry. Results Compared with the control group, the expression and the positive ratio of a-smooth muscle actin in the connective tissue growth factor stimulated group increased. The raise level of a-smooth muscle decreased after the pretreatment of PI3K inhibitor LY294002. The results were markedly different by statistic analysis(P<0.05). Conclusion Connective tissue growth factor can promote the transdifferentation of human hypertrophic scar fibroblasts mediated by PI3K/PKB signaling pathway. This effect can be inhibited by LY294002.
What problem does this paper attempt to address?